---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-017323"
form_type: "8-K/A"
ticker: "APUS"
cik: "0001894525"
company_name: "Apimeds Pharmaceuticals US, Inc."
filed_at: "2026-02-17T23:59:59+00:00"
generated_at: "2026-05-16T02:33:39.941877+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# MindWave posts six-month net loss $6.6M on zero revenue; digital assets $132.3M

## Summary
- Net loss $6.6M for six months ended Sep 30, 2025 vs net income $57.8M in prior year period.
- No revenue from operations; digital assets at fair value $132.3M (incl. restricted).
- Total equity $132.3M, zero liabilities; unrealized loss $9.1M from digital asset remeasurement.
- Financials filed as Exhibit 99.1 for reverse merger with Apimeds (APUS) previously reported.
- Company holds crypto tokens ($NILA) and generates gains mainly from sale of digital assets.

## SEC filing metadata
- accession: 0001213900-26-017323
- form_type: 8-K/A
- ticker: APUS
- cik: 0001894525
- company_name: Apimeds Pharmaceuticals US, Inc.
- filed_at: 2026-02-17T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 9.01, 2.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1894525/000121390026017323/0001213900-26-017323-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1894525/000121390026017323/ea0277267-8ka2_api.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-017323
- JSON: https://secwatch.observer/filing/0001213900-26-017323.json
- Plain text: https://secwatch.observer/filing/0001213900-26-017323.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.